Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.480
+0.060 (2.48%)
Feb 27, 2026, 9:38 AM EST - Market open
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $196.79 million as of February 27, 2026. Its market cap has decreased by -23.92% in one year.
Market Cap
196.79M
Enterprise Value
99.35M
1-Year Change
-23.92%
Ranking
Category
Stock Price
$2.48
Market Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $196.79M, an increase of 340.65%. That is a compound annual growth rate of 18.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 192.03M | 69.23% |
| Dec 31, 2025 | 113.47M | -53.90% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 203.73M |
| Caribou Biosciences | 200.02M |
| Heron Therapeutics | 199.87M |
| Ovid Therapeutics | 196.58M |
| Cartesian Therapeutics | 196.33M |
| Sagimet Biosciences | 192.53M |
| NeOnc Technologies Holdings | 188.90M |
| Molecular Partners AG | 188.55M |